Acumen Pharmaceuticals (ABOS) Payables (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Payables of $15.8 million for Q1 2026, up 69.31% sequentially from $9.3 million in Q4 2025, and up 1394.13% YoY from $1.1 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Payables (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Payables for 7 years, with the latest figure at $15.8 million in Q1 2026.
- Quarterly Payables rose 1394.13% year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (up 1394.13% YoY) and the FY2025 annual result came in at $9.3 million, up 65.0% from the prior year.
- Payables rose to $15.8 million in Q1 2026 per ABOS's latest filing, from $9.3 million in the prior quarter.
- Over five years, Payables peaked at $15.8 million in Q1 2026 and troughed at $762000.0 in Q1 2023.
- A 5-year average of $3.5 million and a median of $2.1 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2025 and 2026: Payables tumbled 65.7% in 2025, then soared 1394.13% in 2026.
- Over 5 years, Payables stood at $1.6 million in 2022, then dropped by 15.91% to $1.4 million in 2023, then soared by 309.57% to $5.6 million in 2024, then surged by 65.0% to $9.3 million in 2025, then surged by 69.31% to $15.8 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $15.8 million, $9.3 million, and $4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 35.57 Mn |
| 10 | Acumen Pharmaceuticals | 230.12 Mn | 230.12 Mn | - | 33.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.05 Mn |
| Mar 31, 2026 | 15.78 Mn |
| Dec 31, 2025 | 9.32 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 5.65 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 762,000.00 |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 382,000.00 |